INVESTORS & MEDIA

44th Annual Meeting of the European Society for Blood and Marrow Transplantation

Mar 19, 2018 at 9:00 AM GMT


Additional Information

Atara and its collaborating investigator at the University of North Carolina at Chapel Hill will present findings from a comprehensive literature review of the mortality burden of post-transplant lymphoproliferative disorder (PTLD) in patients who have received an allogeneic hematopoietic cell transplant (HCT). The poster will be featured during the upcoming 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), which will be held in Lisbon, Portugal, March 18-21, 2018. Details for the presentation are as follows:

 

Abstract Title: Burden of Post-Transplant Lymphoproliferative Disorder-Mortality After Allogeneic Hematopoietic Cell Transplantation

Poster Session Title: Early Complications / Late Effects & Quality of Life

Presentation Date & Time: Monday, March 19, 2018; 9:00AM - 5:00PM WET

Lead Authors: Aaron Katz, Pharm.D., Ph.D.; Arie Barlev, Pharm.D., M.S.; and AJ Joshi, M.D.

Abstract: A219 http://ebmt2018.org/scientific-programme/

Location: Pavilion 1, Centro de Congressos de Lisboa / Lisbon Congress Centre (LCC)